Women's Health & Pregnancy Clinical Trials

Statistical methods in women's health & pregnancy trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All women's health & pregnancy trials

790 results

• Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT): Complete Statistical AnalysisIndependent statistical analysis of Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00135811).Phase 3Results postedn = 192NCT00135811
• Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor: Complete Statistical AnalysisIndependent statistical analysis of Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor: primary endpoint results, effect estimate with confidence interval,…Phase 4Results postedn = 121NCT02150954
• Foot Neuromodulation for Nocturnal Enuresis: Complete Statistical AnalysisIndependent statistical analysis of Foot Neuromodulation for Nocturnal Enuresis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02315560).Phase NAResults postedn = 25NCT02315560
• FORTRESSIndependent statistical analysis of Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 432NCT03786094
• FRONTIERIndependent statistical analysis of Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 289NCT05085275
• Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: Complete Statistical AnalysisIndependent statistical analysis of Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00543127).Phase 3Results postedn = 870NCT00543127
• Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): Complete Statistical AnalysisIndependent statistical analysis of Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138124).Phase NAResults postedn = 54,202NCT01138124
• Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 32NCT02040532
• Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide: Complete Statistical AnalysisIndependent statistical analysis of Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 72NCT05033041
• Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00388154).Phase 2Results postedn = 21NCT00388154
• Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 506NCT00942331
• Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 26NCT02178241
• Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 10NCT00201760
• Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2/3Results postedn = 23NCT03503513
• Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): Complete Statistical AnalysisIndependent statistical analysis of Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 430NCT03057808
• GETUGV04Independent statistical analysis of A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 69NCT01495676
• Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: Complete Statistical AnalysisIndependent statistical analysis of Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 114NCT00911625
• GLIMPIndependent statistical analysis of Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 7NCT05254418
• Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: Complete Statistical AnalysisIndependent statistical analysis of Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 496NCT02143713
• Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy: Complete Statistical AnalysisIndependent statistical analysis of Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 14NCT02012608
• GRAMSIndependent statistical analysis of Gadobutrol Enhanced MRA of the Renal Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01344460).Phase 3Results postedn = 317NCT01344460
• Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1/2Results postedn = 6NCT05041101
• Green Tea and Reduction of Breast Cancer Risk: Complete Statistical AnalysisIndependent statistical analysis of Green Tea and Reduction of Breast Cancer Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00917735).Phase 2Results postedn = 1,075NCT00917735
• GSK1120212+GSK2141795 for Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212+GSK2141795 for Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01958112).Phase 2Results postedn = 14NCT01958112
• Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 15NCT02696759
• H42/H4UIndependent statistical analysis of Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 534NCT04724330
• HALT PKD AIndependent statistical analysis of HALT Progression of Polycystic Kidney Disease Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00283686).Phase 3Results postedn = 558NCT00283686
• HALT-DIndependent statistical analysis of Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 53NCT02910219
• Hand-carried Ultrasound to Assess Hydronephrosis: Complete Statistical AnalysisIndependent statistical analysis of Hand-carried Ultrasound to Assess Hydronephrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03774719).Phase NAResults postedn = 6NCT03774719
• Handgrip Exercise for Arteriovenous Fistula Maturation: Complete Statistical AnalysisIndependent statistical analysis of Handgrip Exercise for Arteriovenous Fistula Maturation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061008).Phase NAResults postedn = 31NCT01061008
• HDIL2/EmendIndependent statistical analysis of Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 13NCT01874119
• Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic: Complete Statistical AnalysisIndependent statistical analysis of Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 6,894NCT04385238
• Health Gatherings – For Your Health After Cancer: Complete Statistical AnalysisIndependent statistical analysis of Health Gatherings - For Your Health After Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03344757).Phase NAResults postedn = 188NCT03344757
• HEIRitageIndependent statistical analysis of Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05530356).Phase NAResults postedn = 57NCT05530356
• HELPS-HDIndependent statistical analysis of Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 10,457NCT02933151
• Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure: Complete Statistical AnalysisIndependent statistical analysis of Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2/3Results postedn = 55NCT00318812
• High-dose Bevacizumab in Advanced Renal Carcinoma Patients: Complete Statistical AnalysisIndependent statistical analysis of High-dose Bevacizumab in Advanced Renal Carcinoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455975).Phase 2Results postedn = 119NCT00455975
• HiRTIndependent statistical analysis of Hyperglycemia in Renal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643382).Phase NAResults postedn = 60NCT01643382
• Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 6NCT01249157
• HIV and Kidney Function Study: Complete Statistical AnalysisIndependent statistical analysis of HIV and Kidney Function Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00905151).Phase NAResults postedn = 206NCT00905151
• HOMEIndependent statistical analysis of Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 220NCT06276647
• Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: Complete Statistical AnalysisIndependent statistical analysis of Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04005391).Phase NAResults postedn = 208NCT04005391
• Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01633814).Phase NAResults postedn = 4NCT01633814
• Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 59NCT01293032
• Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05175599).Phase NAResults postedn = 186NCT05175599
• HSG and Tubal Patency Study: Complete Statistical AnalysisIndependent statistical analysis of HSG and Tubal Patency Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02146248).Phase NAResults postedn = 11NCT02146248
• HyCoSyIndependent statistical analysis of Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 21NCT02628873
• Hydrocortisone for BPD: Complete Statistical AnalysisIndependent statistical analysis of Hydrocortisone for BPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01353313).Phase 3Results postedn = 800NCT01353313
• Hyp-hOPIndependent statistical analysis of Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 165NCT01829425
• hyperPOCIndependent statistical analysis of Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 156NCT03184519

← All therapeutic areas